{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:52Z","timestamp":1793039392327,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201413-30"],"award-info":[{"award-number":["201413-30"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Ministry MINECO\/FEDER","award":["SAF2017-84117-R"],"award-info":[{"award-number":["SAF2017-84117-R"]}]},{"name":"the Ministry MINECO\/FEDER","award":["SAF2015-68580-C2-2-R"],"award-info":[{"award-number":["SAF2015-68580-C2-2-R"]}]},{"name":"the Carlos III Research Institute"},{"name":"the State Plan for Scientific and Technical Research and Innovation"},{"name":"the European Regional Development"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neuropharm.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T19:39:40Z","timestamp":1549741180000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage"],"prefix":"10.1016","volume":"152","author":[{"given":"Rafael","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Reyes-Resina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guti\u00e9rrez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Jagerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4405-3545","authenticated-orcid":false,"given":"Jos\u00e9","family":"Mart\u00ednez-Orgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-0873","authenticated-orcid":false,"given":"Gemma","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm0901-1003","article-title":"Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness","volume":"7","author":"AbdAlla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib2","article-title":"Cocaine blocks effects of hunger hormone, ghrelin, via interaction with neuronal sigma-1 receptors","author":"Aguinaga","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1527-3458.2005.tb00055.x","article-title":"A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke","volume":"11","author":"Berends","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2016.12.017","article-title":"Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke","volume":"116","author":"Cepri\u00e1n","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070849","article-title":"Cannabinoid receptor CB2 modulates axon guidance","volume":"8","author":"Duff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib8","first-page":"348","article-title":"Cannabinoids in experimental stroke: a systematic review and meta-analysis","volume":"35","author":"England","year":"2015","journal-title":"J. Perinatol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/phar.1780","article-title":"Current status and prospects for cannabidiol preparations as new therapeutic agents","volume":"36","author":"Fasinu","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nchembio0309-131","article-title":"Building a new conceptual framework for receptor heteromers","volume":"5","author":"Ferr\u00e9","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphar.2016.00076","article-title":"Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization","volume":"7","author":"Franco","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/pr.2016.149","article-title":"Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets","volume":"80","author":"Garberg","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in gene and protein expression of cannabinoid CB2 and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims","volume":"15","author":"Garc\u00eda-Guti\u00e9rrez","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.neuropharm.2019.02.004_bib1a","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1523\/JNEUROSCI.13-08-03510.1993","article-title":"Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury","volume":"13","author":"Goldberg","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib2a","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-62703-230-8_10","article-title":"Super-resolution microscopy of the neuronal calcium-binding proteins Calneuron-1 and Caldendrin","volume":"963","author":"Hradsky","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.019","article-title":"Drug-induced hypothermia by 5HT1A agonists provide neuroprotection in experimental stroke: new perspectives for acute patient treatment","volume":"23","author":"Johansen","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fnins.2016.00323","article-title":"Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia","volume":"10","author":"Lafuente","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10072-014-1958-3","article-title":"New expression of 5-HT1A receptor in astrocytes in the gerbil hippocampal CA1 region following transient global cerebral ischemia","volume":"36","author":"Lee","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1568007053544165","article-title":"Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke","volume":"4","author":"Lutsep","year":"2005","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/jm2007886","article-title":"New serotonin 5-HT 1A receptor agonists with neuroprotective effect against ischemic cell damage","volume":"54","author":"Marco","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jcbfm.9600038","article-title":"Neuroprotective efficacy of repinotan HCl, a 5-HT 1A receptor agonist, in animal models of stroke and traumatic brain injury","volume":"25","author":"Mauler","year":"2005","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clp.2016.04.007","article-title":"Neonatal encephalopathy: update on therapeutic hypothermia and other novel therapeutics","volume":"43","author":"McAdams","year":"2016","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10517-016-3445-8","article-title":"The role of 5-HT1A receptors in long-term adaptation of newborn rats to hypoxia","volume":"161","author":"Mikhailenko","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-Hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib27","first-page":"27","article-title":"Neuroprotective effects of cannabidiol in hypoxic ischemic insult: the therapeutic window in newborn mice","volume":"27","author":"Mohammed","year":"2016","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acs.jmedchem.6b00397","article-title":"Chromenopyrazole, a versatile cannabinoid scaffold with in vivo activity in a model of multiple sclerosis","volume":"59","author":"Morales","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2017.00422","article-title":"An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Relevance for Alzheimer's disease and levo-dopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12915-018-0491-x","article-title":"Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain","volume":"16","author":"Navarro","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12915-016-0247-4","article-title":"Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs","volume":"14","author":"Navarro","year":"2016","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1074\/jbc.M111.291294","article-title":"CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling","volume":"287","author":"Palazuelos","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia\u2013ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT1A and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib36","first-page":"308","article-title":"Neurotrophic factors (BDNF and GDNF) and the serotonergic system of the brain","volume":"82","author":"Popova","year":"2017","journal-title":"Biochem"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2004.10.019","article-title":"The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization","volume":"1030","author":"Ramos","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mcn.2017.09.009","article-title":"Dual effect of serotonin on the dendritic growth of cultured hippocampal neurons: involvement of 5-HT1Aand 5-HT7receptors","volume":"85","author":"Rojas","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib39","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jnr.23390","article-title":"Serotonin (5-HT) regulates neurite outgrowth through 5-HT 1A and 5-HT 7 receptors in cultured hippocampal neurons","volume":"92","author":"Rojas","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib41","first-page":"624","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.neuropharm.2019.02.004_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ph10040079","article-title":"Orexin receptor multimerization versus functional interactions: neuropharmacological implications for opioid and cannabinoid signalling and pharmacogenetics","volume":"10","author":"Thompson","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.neuropharm.2019.02.004_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12975-012-0197-2","article-title":"Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke","volume":"3","author":"Zhang","year":"2012","journal-title":"Transl. Stroke Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:55:12Z","timestamp":1758437712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":45,"alternative-id":["S0028390819300462"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}